| (ENZN) NASDAQ | |
| Last Trade | 10.310 |
| Change(%) |
0.46
|
| Volume | 1,303,400 |
| Mar 10, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
--Debt converted into an additional 13.5 million shares--
Jeffrey Buchalter Steps Down as CEO of Enzon
--Sale of Specialty Pharmaceutical Business brings over $300
million in value--
